Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carotenoid pigment replenishment in the retina refers to the uptake, transport, binding, and metabolism of dietary carotenoids—primarily lutein, zeaxanthin, and meso-zeaxanthin—within retinal tissues[2][3][4]. These carotenoids act as **antioxidants** and **blue light filters**, protecting the macula and photoreceptors from oxidative damage caused by high-energy visible light and reactive oxygen species. Because humans cannot synthesize these carotenoids, their retinal levels depend on dietary intake and the function of specific transporters (such as GRAMD1B), enzymes (BCO2), and binding proteins (GSTP1, StARD3)[1][2]. Deficiencies or impaired replenishment increase the risk of diseases such as **age-related macular degeneration** and cataract[3][4]. Supplementation with lutein and zeaxanthin is widely used to increase macular pigment density, thereby supporting retinal health and reducing disease risk[4].
Increase macular pigment density by supplying exogenous carotenoids Antioxidant action to counteract reactive oxygen species (ROS) Blue light filtering
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carotenoid pigment replenishment in retina.